← FDA Drug Approvals (Drugs@FDA)

ENSACOVE

NDA · New Drug Application · Sponsor: XCOVERY · Approved 2024-12-18

Drug application

FDA Application #

NDA218171

Application type

New Drug Application

Brand name

ENSACOVE

Generic name

ENSARTINIB

Active ingredients

ENSARTINIB HYDROCHLORIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

XCOVERY

Manufacturer

Xcovery Holdings, Inc.

First approval

2024-12-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown